Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 19101-19150 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02455141
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
PHASE3
Active, not recruiting
786 participants
Started: Mar 31, 2016 · Completed: Mar 31, 2030
1 condition
1 sponsor
27 locations
NCT02514525
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
NA
Active, not recruiting
150 participants
Started: Mar 31, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
11 locations
NCT02726763
Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training
NA
Active, not recruiting
18 participants
Started: Mar 30, 2016 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT02451982
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
PHASE2
Active, not recruiting
76 participants
Started: Mar 28, 2016 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT02446600
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE3
Active, not recruiting
579 participants
Started: Mar 28, 2016 · Completed: Aug 23, 2026
13 conditions
3 sponsors
356 locations
NCT02688712
ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer
PHASE2
Active, not recruiting
50 participants
Started: Mar 24, 2016 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05456334
New Treatments for Actinic Keratoses of the Scalp
NA
Active, not recruiting
120 participants
Started: Mar 24, 2016 · Completed: Dec 31, 2024
2 conditions
1 sponsor
0 locations
NCT02900833
Impact of Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy
N/A
Active, not recruiting
440 participants
Started: Mar 24, 2016 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT07154537
Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)
PHASE4
Active, not recruiting
101 participants
Started: Mar 23, 2016 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT02638090
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
PHASE1/PHASE2
Active, not recruiting
120 participants
Started: Mar 22, 2016 · Completed: Jan 21, 2026
2 conditions
2 sponsors
1 location
NCT02632409
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
PHASE3
Active, not recruiting
709 participants
Started: Mar 22, 2016 · Completed: May 27, 2027
1 condition
2 sponsors
188 locations
NCT02867033
National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)
NA
Active, not recruiting
628 participants
Started: Mar 22, 2016 · Completed: Nov 30, 2031
1 condition
4 sponsors
38 locations
NCT02644369
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
PHASE2
Active, not recruiting
100 participants
Started: Mar 21, 2016 · Completed: Dec 31, 2026
5 conditions
2 sponsors
1 location
NCT04439188
Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)
PHASE2
Active, not recruiting
35 participants
Started: Mar 21, 2016 · Completed: Dec 31, 2026
6 conditions
1 sponsor
1 location
NCT02629809
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
PHASE2
Active, not recruiting
81 participants
Started: Mar 18, 2016 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT02734004
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
PHASE1/PHASE2
Active, not recruiting
264 participants
Started: Mar 17, 2016 · Completed: Sep 17, 2025
4 conditions
2 sponsors
47 locations
NCT02742493
RCT for the Effectiveness of 3 Orthodontic Retention Schemes on Post-treatment Stability and Gingival Recession
NA
Active, not recruiting
60 participants
Started: Mar 16, 2016 · Completed: Nov 1, 2025
2 conditions
1 sponsor
1 location
NCT02500849
Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients
PHASE1
Active, not recruiting
12 participants
Started: Mar 10, 2016 · Completed: Aug 24, 2026
1 condition
3 sponsors
5 locations
NCT02653105
Women at Risk of Breast Cancer and OLFM4
NA
Active, not recruiting
150 participants
Started: Mar 8, 2016 · Completed: Mar 31, 2026
1 condition
1 sponsor
4 locations
NCT02535312
Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Mar 8, 2016 · Completed: Oct 17, 2025
7 conditions
1 sponsor
14 locations
NCT02717611
A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy
PHASE2
Active, not recruiting
60 participants
Started: Mar 8, 2016 · Completed: Sep 6, 2026
1 condition
1 sponsor
23 locations
NCT02192359
Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PHASE1
Active, not recruiting
18 participants
Started: Mar 7, 2016 · Completed: Oct 15, 2025
7 conditions
2 sponsors
1 location
NCT03705546
The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer
N/A
Active, not recruiting
1,050 participants
Started: Mar 4, 2016 · Completed: Mar 3, 2026
1 condition
1 sponsor
1 location
NCT02716012
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
PHASE1
Active, not recruiting
75 participants
Started: Mar 1, 2016 · Completed: Jul 31, 2025
2 conditions
1 sponsor
11 locations
NCT03330587
Living Alone in Old Age With Cognitive Impairment
N/A
Active, not recruiting
60 participants
Started: Mar 1, 2016 · Completed: May 31, 2025
3 conditions
1 sponsor
1 location
NCT03749343
International T1 Multicenter Outcome Study
N/A
Active, not recruiting
8,000 participants
Started: Mar 1, 2016 · Completed: Feb 28, 2030
5 conditions
3 sponsors
3 locations
NCT02673333
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
PHASE2
Active, not recruiting
39 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
1 condition
2 sponsors
2 locations
NCT02689648
Long Term Follow up on Functional Gastrointestinal Disorder (FGID)
N/A
Active, not recruiting
400 participants
Started: Feb 29, 2016 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT02692807
Arthroscopic Surgical Procedures vs Sham Surgery for Patients With Femoroacetabular Impingement and/or Labral Tears.
NA
Active, not recruiting
140 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2035
1 condition
6 sponsors
2 locations
NCT02766231
Physica CR and Physica PS Clinical Trial
N/A
Active, not recruiting
157 participants
Started: Feb 29, 2016 · Completed: Jun 30, 2028
1 condition
1 sponsor
4 locations
NCT02677051
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
PHASE2
Active, not recruiting
48 participants
Started: Feb 29, 2016 · Completed: Jul 31, 2025
4 conditions
2 sponsors
1 location
NCT02697396
Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children
N/A
Active, not recruiting
181 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
1 condition
3 sponsors
1 location
NCT02357797
Adjunctive Vortioxetine in Schizophrenia
PHASE4
Active, not recruiting
88 participants
Started: Feb 29, 2016 · Completed: Jun 1, 2024
2 conditions
2 sponsors
3 locations
NCT02673931
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
NA
Active, not recruiting
1,400 participants
Started: Feb 29, 2016 · Completed: Sep 30, 2024
6 conditions
1 sponsor
1 location
NCT02491697
Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer
PHASE2
Active, not recruiting
400 participants
Started: Feb 29, 2016 · Completed: Aug 31, 2033
1 condition
1 sponsor
0 locations
NCT02597348
Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy
NA
Active, not recruiting
94 participants
Started: Feb 29, 2016 · Completed: Jul 31, 2026
3 conditions
1 sponsor
1 location
NCT02701829
Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support
NA
Active, not recruiting
166 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT02494167
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
PHASE1
Active, not recruiting
44 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2027
2 conditions
5 sponsors
2 locations
NCT02706262
Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health
NA
Active, not recruiting
180 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT02465307
Intelligent Intensive Care Unit
N/A
Active, not recruiting
130 participants
Started: Feb 29, 2016 · Completed: May 30, 2028
2 conditions
4 sponsors
1 location
NCT02986243
Preparing for Kidney Transplant by Attaining a Healthy Weight
NA
Active, not recruiting
10 participants
Started: Feb 29, 2016 · Completed: Nov 30, 2025
1 condition
1 sponsor
0 locations
NCT02676973
Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design
NA
Active, not recruiting
360 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2026
1 condition
13 sponsors
10 locations
NCT02678299
Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study
PHASE1/PHASE2
Active, not recruiting
60 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
18 locations
NCT02611453
Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP
NA
Active, not recruiting
40 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT02603341
Pragmatic Randomized Trial of Proton Vs. Photon Therapy for Patients with Non-Metastatic Breast Cancer: a Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
NA
Active, not recruiting
1,238 participants
Started: Feb 29, 2016 · Completed: Nov 30, 2036
1 condition
2 sponsors
40 locations
NCT05982574
Tumor Microenvironment
N/A
Active, not recruiting
300 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT02693990
A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
NA
Active, not recruiting
21 participants
Started: Feb 29, 2016 · Completed: Aug 31, 2027
2 conditions
2 sponsors
2 locations
NCT02489890
CIK in Treating Patients With Bladder Cancer
PHASE2
Active, not recruiting
1,500 participants
Started: Feb 29, 2016 · Completed: Jul 31, 2030
1 condition
1 sponsor
0 locations
NCT02710370
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
N/A
Active, not recruiting
46 participants
Started: Feb 29, 2016 · Completed: Aug 31, 2028
5 conditions
4 sponsors
1 location
NCT02675829
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
PHASE2
Active, not recruiting
131 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
4 conditions
2 sponsors
7 locations
Previous
1
More pages
380
381
382
383
384
385
386
More pages
431
Next